Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT05524428
Status
Recruiting
Apply to this trial

Conditions

  • Colo-rectal Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Implementation Science Strategy — BEHAVIORAL
    The investigators will be conducting focus groups and identifying barriers and facilitators, and the investigators will be matching identified barriers and facilitators to implementation strategies at the patient, provider, and system level which the investigators will be testing using rapid-cycle methods.

Study Details

The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.

Key Dates

Start date
Mar 24, 2023
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
2 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SCREENING

Arms

  • Other: Introduction of Implementation Strategies
    The investigators will determine the best intervention and strategy (and thus implementers) based on high ranking barriers/facilitators identified in focus groups. A minimum of 2 implementation strategies will be developed and implemented at each level (patient, provider, system) at each site that considers (1) implementation strategy; (2) mechanism in which the strategy impacts the identified determinant (3) the determinant; (4) moderators that may influence the impact of the strategy; (5) the preconditions necessary for successful implementation; and (6) implementation outcomes affected. Each community health center (CHC) will serve as its own separate subject, and individual strategies will be tested using single case experimental design (SCED) at each CHC using component analysis to rapidly test and optimize our strategies. In SCED each subject serves as their own control, an intervention is systematically introduced and withdrawn, and the effects of the intervention are measured.
  • No Intervention: Withdrawal of Implementation Strategies
    In SCED each subject serves as their own control, an intervention is systematically introduced and withdrawn, and the effects of the intervention are measured.

Primary Outcome Measure

Primary Outcome 1: Acceptability of Implementation Strategies [ Time Frame: 4 months ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Codman Square Health CenterBostonMassachusetts02124
Stephen Tringale, MD
Brockton Neighborhood Health CenterBrocktonMassachusetts02301
Madhur Kuckreja, MD
East Boston Neighborhood Health CenterEast BostonMassachusetts02128
Heidi Emerson, PhD
Duffy Health CenterHyannisMassachusetts02601
Lisa Jones, MD

Find similar trials in Boston, MA

By research site
Codman Square Health Center· Boston, MABrockton Neighborhood Health Center· Brockton, MAEast Boston Neighborhood Health Center· East Boston, MADuffy Health Center· Hyannis, MA

Related Studies